Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, Cui X, Murali R, Namba K, Sato H, Torigoe H, Watanabe M, Shien K, Soh J, Asano H, Tsukuda K, Kitamura Y, Miyoshi S, Sendo T, Toyooka S. Takeda T, et al. PLoS One. 2017 Feb 3;12(2):e0171356. doi: 10.1371/journal.pone.0171356. eCollection 2017. PLoS One. 2017. PMID: 28158234 Free PMC article.
Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.
Torigoe H, Shien K, Takeda T, Yoshioka T, Namba K, Sato H, Suzawa K, Yamamoto H, Soh J, Sakaguchi M, Tomida S, Tsukuda K, Miyoshi S, Toyooka S. Torigoe H, et al. Among authors: takeda t. Cancer Sci. 2018 May;109(5):1493-1502. doi: 10.1111/cas.13571. Epub 2018 Apr 15. Cancer Sci. 2018. PMID: 29532558 Free PMC article.
Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma.
Namba K, Tomida S, Matsubara T, Takahashi Y, Kurihara E, Ogoshi Y, Yoshioka T, Takeda T, Torigoe H, Sato H, Shien K, Yamamoto H, Soh J, Tsukuda K, Toyooka S. Namba K, et al. Among authors: takeda t. BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1. BMC Cancer. 2019. PMID: 30808329 Free PMC article.
Acquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells.
Yoshioka T, Shien K, Takeda T, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Soh J, Fujiwara T, Toyooka S. Yoshioka T, et al. Among authors: takeda t. Cancer Sci. 2019 Aug;110(8):2549-2557. doi: 10.1111/cas.14089. Epub 2019 Jun 24. Cancer Sci. 2019. PMID: 31162771 Free PMC article.
Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation.
Miyauchi S, Shien K, Takeda T, Araki K, Nakata K, Miura A, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Suzawa K, Yamamoto H, Okazaki M, Soh J, Tomida S, Yamane M, Sakaguchi M, Toyooka S. Miyauchi S, et al. Among authors: takeda t. Anticancer Res. 2020 May;40(5):2667-2673. doi: 10.21873/anticanres.14237. Anticancer Res. 2020. PMID: 32366411 Free article.
Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer.
Ochi K, Suzawa K, Tomida S, Shien K, Takano J, Miyauchi S, Takeda T, Miura A, Araki K, Nakata K, Yamamoto H, Okazaki M, Sugimoto S, Shien T, Yamane M, Azuma K, Okamoto Y, Toyooka S. Ochi K, et al. Among authors: takeda t. Biochem Biophys Res Commun. 2020 Aug 27;529(3):760-765. doi: 10.1016/j.bbrc.2020.06.077. Epub 2020 Jul 19. Biochem Biophys Res Commun. 2020. PMID: 32736704 Free article.
3,770 results